DBV Technologies (ADR) (DBVT)
Develops an investigational skin patch for peanut allergy using epicutaneous immunotherapy.
$13.00
After hours+0.32 (+2.48%)
At close$12.69(+4.83%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 36.36% | 21.53M ADS | |
|---|---|---|---|
| 78 holders · as of Jun 30, 2026 | |||
| Insiders | 2.68% | 1.59M ADS | |
| 6 holders · as of Jul 31, 2026 | |||
| Strategic holders | 3.60% | 2.13M ADS | |
| 1 holder · as of Apr 7, 2025 | |||
| Other | 57.36% | 33.96M ADS | |
| remainder | |||
59.21M ADS (1 ADS = 5 ordinary shares) as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (59.21M in the company's Sep 22, 2026 report, 23.92M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
78 holders · 21.53M shares · 17 new positions · 34 increased · 24 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bioimpact Capital LLC | 3.67M | 6.19% | −1.55M | Aug 14, 2026 |
| Siren, L.L.C. | 1.86M | 3.14% | 0 | Aug 13, 2026 |
| Vivo Capital, LLC | 1.84M | 3.12% | −822.8K | Aug 14, 2026 |
| Perceptive Advisors LLC | 1.65M | 2.79% | +689.0K | Aug 14, 2026 |
| Baker Bros. Advisors LP | 1.46M | 2.47% | 0 | Aug 14, 2026 |
| Artisan Partners Limited Partnership | 1.37M | 2.32% | −846.5K | Aug 13, 2026 |
| UBS Group AG | 1.31M | 2.22% | +1.23M | Aug 13, 2026 |
| Morgan Stanley | 954.9K | 1.61% | +808.8K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Julian C. Baker +1 more | 17.10% | 23.49M | 13D | Mar 31, 2025 |
| Baker Bros. Advisors LP | 9.99% | 13D | Jan 14, 2026 | |
| Suvretta Capital Management, LLC | 9.90% | 15.18M | 13G | Apr 11, 2025 |
| MPM BioImpact LLC | 8.80% | 13G | May 15, 2026 | |
| Adage Capital Management, L.P. | 7.31% | 13G | May 13, 2026 | |
| Citadel Advisors LLC | 6.40% | 9.16M | 13G | Apr 14, 2025 |
| Invus Public Equities, L.P. | 6.10% | 13G | May 5, 2026 | |
| RA Capital Management, L.P. | 5.80% | 13G | Aug 6, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 29, 2026 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 464 | $2.70 | 144,531 |
| Jan 29, 2026 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 534 | $4.86 | 144,995 |
| Dec 18, 2025 | Bpifrance EPICother: Member of 10% owner group | Sale | 1,292,103 | $4.19 | 7,303,369 |
| Dec 17, 2025 | Bpifrance EPICother: Member of 10% owner group | Sale · 2 lots | 2,076,990 | $4.85 | 8,595,472 |
| Nov 21, 2025 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 1,624 | $2.77 | 101,529 |
| Nov 20, 2025 | Pharis Mohideenofficer: Chief Medical Officer | Sale | 6,496 | $2.88 | 103,153 |
House and Senate disclosures
Not reported.